Introduction
============

Stomach or gastric cancer (GC) is the malignant growth of stomach cells ([@b1-ijph-40-80]), which can develop in any part of the stomach and may spread throughout the stomach and to other organs; particularly the esophagus, lungs and the liver ([@b2-ijph-40-80]). After cancer of lung, breast, and colerectum, GC is the fourth most commonly occurring cancer throughout the world ([@b3-ijph-40-80]). Generally, GC has reported the second most common cancer related cause of death in the world ([@b3-ijph-40-80], [@b4-ijph-40-80]).

In the past two decades, because of the promotion of hygiene in Iran, death from different disease has reduced, but death rates due to cancers have remained as a major health problem in Iranian people ([@b5-ijph-40-80], [@b6-ijph-40-80]).

In the last decades, the data analysts have proposed and used a variety of survival methods for describing the connection between the outcome variable and a host of covariates in different fields of medical sciences. In this context, the usual survival methods such as Cox proportional hazard modeling are still the most common approach for analyzing these kinds of data sets. However, when we use this model some underlying assumptions including proportionality of hazards and independency of covariates affecting hazard rate should be considered ([@b7-ijph-40-80], [@b8-ijph-40-80]). When these assumptions are not acceptable, we should use other free assumption modeling approaches such as artificial neural networks (ANNs).

Indeed, ANN models attempt to model the capabilities of human brains and are being used in areas of prediction and classification, where regression models and other related statistical techniques have traditionally been used([@b9-ijph-40-80]).

In addition, ANN models have been used in medical fields for classification and for prediction of outcome ([@b10-ijph-40-80]).

In this manuscript, we have developed the ANN strategy for analyzing the survival data from 436 patients with stomach cancer. The aim of this study was also to compare the results obtained by ANN and traditional Cox regression analyses for predicting the survival rate of these patients.

Materials and Methods
=====================

Main outcome and related factors
--------------------------------

We analyzed the data from 436 patients with stomach cancer who underwent operation between 2002 and 2007 at the Taleghani Hospital (a referral center for gastrointestinal cancers), Tehran, Iran. This study was conducted by the Research Center for Gastroenterology and Liver Disease of Shahid Beheshti University of Medical Sciences, Tehran, Iran. All the patients were diagnosed by endoscopy and/or biopsies. In this historical cohort study, the required information for each patient including gender, age at diagnosis, familial history, symptoms at diagnosis, high-risk behaviors (such as smoking, drug use and alcohol drinking), lymph nodes metastasis, extent of wall penetration, type of histology, tumor stage and metastasis was gathered from his/her registered documents in the Cancer Archive of Taleghani Hospital. The patients who had not completed document or treated out of the time February 2002 to January 2007 were excluded. In addition, the patients who have had lower than one-month survival time were excluded. We also registered the survival time of each patient (in month) after subtotal or total gastrectomy. The survival status of patients was confirmed through contact with their families by telephone. Moreover, the staging of the tumors was based on the sixth edition of the TNM system ([@b11-ijph-40-80]). The study protocol was approved by the Ethics Committee of the Research Centre for Gastroenterology and Liver Disease of Shaheed Beheshti Medical University.

Statistical analysis
--------------------

In the first step of data analysis, because of survival nature of the outcome data, some preliminary analyses such as Kaplan-Meier and log-rank tests have been carried out. In the next step, for predicting the survival rate of the patients, we utilized more complex statistical methods, including Cox proportional hazard (CPH) and ANN models.

In the modeling process, we randomly divided the data in two subsets: 300 patients for constructing the models (training subset) and the remaining (136 patients) for assessing the validation of the models (testing subset). After evaluating the validation, we applied the receiver operation characteristic (ROC) curve as well as the concordance index for comparing the prediction power of the described models. It is worth mentioning that, in fitting ANN model we used a three-layer back-propagation neural network with 10 nodes in input layer, 7 nodes in hidden layer and one node in output layer. Since each patient's status is a binary response variable (dead or censored), the sigmoid function was utilized as the activation function in hidden and output layers. For net training, we have utilized back-propagation learning algorithm with learning rate of 0.05 and momentum of 0.9. The learning process was stopped, when the average error (mean square error) in the training set descended to 0.0001. We also applied the backward selection method (with significant level of entry 0.10, and significant level of removal 0.15) to fit the Cox regression model.

For data analysis, we used the SPSS version 16.0 and the MATLAB version 7.1 softwares.

Results
=======

As described before, the study sample was consisted of 436 GC patients including 315 men (72.2%) and 121 women (27.8%). The mean±SD age of the patients was 58.43±13.02. [Table 1](#t1-ijph-40-80){ref-type="table"} shows other characteristics of the patients under study.

In the first step of the modeling process, the data was divided in training and testing subsets. The log-rank (Mantel-Cox) test showed that the estimated survival curves using the training and testing subsets have no significant difference (*P*= 0.674). Based on Kaplan-Meier method, the mean and median of lifetime in the training subset was 32.86 and 28.3 mo, respectively. In addition, 1--5 yr survival probability in the training part was 0.76, 0.53, 0.35, 0.28, and 0.18, respectively. These rates were, respectively, 0.78, 0.51, 0.41, 0.36 and 0.12 in the testing part. [Table 2](#t2-ijph-40-80){ref-type="table"} shows more details.

For assessing the effect of different risk indicators on survival of the GC patients, we fitted a Cox regression model to the data using backward selection method. [Table 3](#t3-ijph-40-80){ref-type="table"} shows the obtained results. These findings indicated that age at diagnosis (*P*= 0.038), high-risk behaviors (*P*= 0.070), extent of wall penetration (*P*= 0.076), distant metastasis (*P*= 0.003), and tumor stage (*P*= 0.017) have had statistically significant relationship with survival of the GC patients. This analysis revealed no significant relationship between patients' survival and sex, familial history, symptoms at diagnosis, lymph nodes metastasis and histology type.

In the next step, we used the data from testing subset for comparing the accuracy of the models in true classification (the proportion of patients that classified correctly in dead and survived groups) of the patients. The obtained results were shown in [Table 4](#t4-ijph-40-80){ref-type="table"}. In this table, the first row shows the sensitivity (i.e. classification accuracy for positive cases), the second row shows the specificity (i.e. classification accuracy for negative cases), and the third row shows the concordance index (i.e. a proportion of all utilizable patient pairs in which the predictive and observed outcomes are concordant. The values of 0 to 1 indicate model fit.). As we can see, the ANN model lead to more accurate predictions compared to the Cox model (overall true prediction of 83.1% vs. 75.0%). The area under ROC curve, calculated from testing data, for ANN model was 0.92, and for CPH model, 0.88. The difference between two AUC and its SE was 0.04 and 0.0178 respectively, and derived *P*-value was 0.0245.

Discussion
==========

Gastric cancer is very lethal as a fact that the diagnosis of most of patients occurs in the advanced stages ([@b12-ijph-40-80]--[@b15-ijph-40-80]).

Therefore, determining of risk factors and risk indicators, and estimating the survival rate of GC patients are of the great importance. The main aims of the present study were identifying some of the most important related factors of GC and comparing the ability of a traditional survival modeling technique (Cox proportional hazard model) and neural network approach in predicting the survival rate of the GC patients.

In this study, the estimation for the one-year, two-year, three-year, four-year and five-year survival rates for GC patients were, respectively, 77.9%, 53.1%, 40.8%, 32.0%, and 17.4% for the total sample (436 patients). Other studies in Iran showed five-year survival rates between 13% and 18% for the GC patients ([@b13-ijph-40-80]--[@b15-ijph-40-80]). In addition, the reported five-year survival rate of stomach cancer is 29.6% in China, 4.4% in Thailand, 37% in USA,10--20% in European countries ([@b4-ijph-40-80]), 22% in Switzerland, 30% in France, and 40--60% in Japan ([@b3-ijph-40-80], [@b4-ijph-40-80], [@b14-ijph-40-80]).

In this study, the Cox regression analysis showed that the patients' survival time is significantly associated with age at diagnosis, high-risk behaviors, extent of wall penetration, distant metastasis, and tumor stage. Meanwhile, other surveys for Iranian people revealed that tumor size (\>35 mm), presence of lymph node and distant metastasis, elder age at diagnosis and poor differentiated grade were significant risk indicators for lower survival rate of the GC patients ([@b16-ijph-40-80], [@b17-ijph-40-80]). Moreover, published studies from other countries have referred to other risk indicators such as gender, religion, education, number of involved lymph nodes, histological type, and type of complementary treatment as the significant effective factors for survival of the GC patients ([@b18-ijph-40-80]--[@b22-ijph-40-80]).

In the past decades, the statisticians frequently used the traditional methods for analyzing the survival data sets. In recent years, however, more powerful statistical and mathematical softwares enable make use of more sophisticated techniques such as artificial neural network to predict the survival rate of cancer patients more accurately. In this context, the use of ANN for predicting different outcomes in gastric cancer was reported in several articles from different countries. In 2000, a study was conducted to utilize the ANN in the discrimination of benign from malignant gastric cells. The results showed that the ANN could correctly classify 96% of benign cells and 89% of malignant cells ([@b23-ijph-40-80]). In 2008, an ANN-based study was conducted for predicting tumor staging in GC patients and an accuracy of 81.8% for predicting the tumor stage in primary GC patients was reported ([@b24-ijph-40-80]). In Iran, a study applied the Kaplan-Meier, CPH and hierarchical ANN methods for the assessment of GC survival. In overall, there was no significant difference among the survival probabilities or the trend of changes in survival probabilities with the three methods ([@b25-ijph-40-80]). In another study in Taiwan, the ordinary logistic regression, an ANN and decision tree method was used for predicting post-operative complications of GC patients. Results of their study indicated that the ANN was better technique for predicting the post-operative complications compared to logistic regression and decision tree methods ([@b26-ijph-40-80]). A single layer perceptron ANN was applied to data of 4302 GC patients from the National Cancer Center, Tokyo, Japan. Results showed an accuracy of 79% in predicting N (+) or N0 using this method ([@b27-ijph-40-80]). In the present study, we compared the results of CPH and ANN methods in predicting survival of GC patients.

As we know, the predictive results are focused on two aspects: 1) predictive accuracy for the total set of patients of testing data set (i.e. concordance index), and 2) for the two classes of outcomes (dead and survived) that represents sensitivity and specificity respectively. Based on [table 4](#t4-ijph-40-80){ref-type="table"}, the ANN model has better sensitivity and specificity than the Cox model. In addition, concordance index for ANN was 83.1% vs. 75.0% for Cox model that indicate better fit for ANN model. In conclusion, the ANN model had a more accurate prediction of survival rate in GC patients than the CPH model. Therefore, the predicted survival rate obtained by this technique could be used for classifying the high-risk GC patients and allocating the necessary treatments and health resources to these patients.
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###### 

General characteristics of the patients

  **Characteristic**                                                                            **No**   **Percent**
  ---------------------------------------------------------------------------- ---------------- -------- -------------
  Age at diagnosis (yr)                                                        \<=50            128      29.4
  \>50                                                                         308              70.6     
  Familial history                                                             Positive         122      28.0
  Negative                                                                     314              72.0     
  Symptoms at diagnosis                                                        Positive         323      74.1
  Negative                                                                     113              25.9     
  High-risk behaviors                                                          Positive         198      45.4
  Negative                                                                     238              54.6     
  Lymph nodes metastasis^[\*](#tfn1-ijph-40-80){ref-type="table-fn"}^          N1               115      26.4
  N2                                                                           227              52.1     
  N3                                                                           58               13.3     
  Extent of wall penetration ^[\*\*](#tfn2-ijph-40-80){ref-type="table-fn"}^   T1               43       9.9
  T2                                                                           70               16.1     
  T3                                                                           211              48.4     
  T4                                                                           92               21.1     
  Distant metastasis                                                           Presence         71       16.3
  Absence                                                                      322              73.8     
  Histology type                                                               Adenocarcinoma   322      73.8
  Others                                                                       114              26.2     
  Tumor stage                                                                  Early            73       16.7
  Advanced                                                                     319              73.2     

N1: Tumor cells spread to closest or small number of regional lymph nodes; N2: Tumor cells spread to an extent between N1 and N3; N3: Tumor cells spread to most distant or numerous regional lymph nodes.

T1: Tumor invades lamina propria or submucosa; T2: Tumor invades the muscularis propria or the subserosa; T3: Tumor penetrates the serosa (visceral peritoneum) without invading adjacent structures; T4: Tumor invades adjacent structures.

###### 

1--5 year survival probability (±SE) of GC patients in training and testing sets and in total

  **Follow-up period**   **Testing Set: n=136 (Prob.±SE)**   **Training Set: n=300 (Prob.±SE)**   **Total Data: n=436 (Prob.±SE)**
  ---------------------- ----------------------------------- ------------------------------------ ----------------------------------
  One-year               0.78 ± 0.037                        0.76 ± 0.029                         0.78 ± 0.023
  Two-year               0.51 ± 0.055                        0.53 ± 0.039                         0.53 ± 0.032
  Three-year             0.41 ± 0.08                         0.35 ± 0.048                         0.41 ± 0.038
  Four-year              0.36 ± 0.078                        0.28 ± 0.056                         0.32 ± 0.044
  Five-year              0.12 ± 0.075                        0.18 ± 0.064                         0.17 ± 0.050

###### 

CPH modeling results for assessing the effect of prognostic factors on GC patients' survival

  **Prognostic factor**            ***P*-value**        **HR (CI: 95%)**
  -------------------------------- -------------------- ------------------------
  **Age at diagnosis (yrs)**       0.038                1.471 (1.021 -- 2.118)
  **High-risk behaviors**                               
  Absent                           Reference Category   
  Present                          0.070                1.364 (0.976 -- 1.908)
  **Extent of wall penetration**                        
  T1                               Reference Category   
  T2                               0.596                0.724 (0.220 -- 2.387)
  T3                               0.382                1.491 (0.560 -- 4.543)
  T4                               0.052                2.203 (0.992 -- 4.893)
  **Distant metastasis**                                
  Absent                           Reference Category   
  Present                          0.003                1.861 (1.234 -- 2.807)
  **Tumor stage**                                       
  Early                            Reference Category   
  Advanced                         0.017                1.883 (1.121 -- 3.162)

###### 

Classification accuracy of ANN and CPH models in testing subset

  **Status**     **Observed (n)**   **True prediction by ANN n (%)**   **True prediction by CPH n (%)**
  -------------- ------------------ ---------------------------------- ----------------------------------
  **Dead**       51                 41 (80.4)                          32 (62.7)
  **Survived**   85                 72 (84.7)                          70 (82.4)
  **Total**      136                113 (83.1)                         102 (75.0)
